Hologic Stock Alpha and Beta Analysis
| HOLX Stock | USD 79.50 0.06 0.08% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Hologic. It also helps investors analyze the systematic and unsystematic risks associated with investing in Hologic over a specified time horizon. Remember, high Hologic's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Hologic's market risk premium analysis include:
Beta 0.29 | Alpha (0.06) | Risk 1.26 | Sharpe Ratio (0.04) | Expected Return (0.04) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Hologic |
Hologic Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Hologic market risk premium is the additional return an investor will receive from holding Hologic long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Hologic. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Hologic's performance over market.| α | -0.06 | β | 0.29 |
Hologic expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Hologic's Buy-and-hold return. Our buy-and-hold chart shows how Hologic performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Hologic Market Price Analysis
Market price analysis indicators help investors to evaluate how Hologic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hologic shares will generate the highest return on investment. By understating and applying Hologic stock market price indicators, traders can identify Hologic position entry and exit signals to maximize returns.
Hologic Return and Market Media
The median price of Hologic for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 is 80.56 with a coefficient of variation of 1.56. The daily time series for the period is distributed with a sample standard deviation of 1.26, arithmetic mean of 80.53, and mean deviation of 1.03. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | LaFleur Godfrey LLC Sells 4,480 Shares of Hologic, Inc. | 10/16/2024 |
2 | ASX Quarterly Health Wrap Lift-off for ED nasal spray and record users for pregnancy-monitoring platform | 10/29/2024 |
3 | Strong Revenue Growth Highlighted in Hologic Inc Q4 2024 Earnings Call | 11/05/2024 |
4 | Implied Volatility Surging for Hologic Stock Options | 11/08/2024 |
5 | Acquisition by Erik Anderson of 14023 shares of Hologic at 79. subject to Rule 16b-3 | 11/11/2024 |
6 | Disposition of 601 shares by Jan Verstreken of Hologic at 79.29 subject to Rule 16b-3 | 11/12/2024 |
7 | Entropy Technologies LP Takes 1.03 Million Position in Hologic, Inc. | 11/14/2024 |
8 | In Vitro Diagnostics Market, Industry Trends and Forecasts 2018-2023 2024-2035 with Benchmarking Analysis of Abbott, Agilent, BD, bioMerieux, Bio-Rad, Danaher, ... | 11/15/2024 |
9 | Is Weakness In Hologic, Inc. Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects | 11/18/2024 |
10 | Artificial Intelligence In Breast Imaging Market Is Expected To Reach Revenue Of USD 85,443.3 Mn By 2033, At 30.4 percent CAGR Dimension Market Research. | 11/19/2024 |
11 | Earnings call Hologic posts strong Q4 and FY 2024 results, eyes growth | 11/22/2024 |
12 | Hologic, Inc.s Fundamentals Look Pretty Strong Could The Market Be Wrong About The Stock | 11/26/2024 |
13 | CORRECTION RadNets DeepHealth Subsidiary Expands FDA Clearance for SmartMammo Solution | 11/29/2024 |
About Hologic Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Hologic or other stocks. Alpha measures the amount that position in Hologic has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2011 | 2016 | 2022 | 2024 (projected) | Days Sales Outstanding | 57.6 | 46.36 | 54.37 | 56.66 | PTB Ratio | 5.03 | 3.25 | 3.71 | 3.41 |
Hologic Upcoming Company Events
As portrayed in its financial statements, the presentation of Hologic's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Hologic's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Hologic's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Hologic. Please utilize our Beneish M Score to check the likelihood of Hologic's management manipulating its earnings.
| 1st of February 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of November 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Build Portfolio with Hologic
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.